Literature DB >> 11944225

[The effects of hormone replacement therapy (HRT) on the human eye].

Yaron Lang1, Nessia Lang, Moshe Ben-Ami, Hanna Garzozi.   

Abstract

HRT (Hormone Replacement Therapy) is the administration of low estrogen preparation to post-menopausal women. This therapy is considered to be effective in protecting various human tissues from aging processes, which are also related to the decrease in endogenous estrogen level. Estrogen receptors were found in many human tissues and organs, including the eye. Therefore HRT may also have a beneficial effect on the eye and its adnexa. This review presents the ever growing data accumulated over the past years concerning the beneficial effects of HRT on various eye pathologies. It was found that HRT may relieve dry eye symptoms in post-menopausal women, may decrease the intraocular pressure and may delay cataract formation in treated women. In the retina, HRT may play a role in decreasing the incidence of Aging Macular Degeneration (AMD) in post-menopausal women.

Entities:  

Mesh:

Year:  2002        PMID: 11944225

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  3 in total

Review 1.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

2.  The effects of raloxifene hydrochloride on ocular hemodynamics and visual function.

Authors:  Brent Siesky; Alon Harris; Nisha Kheradiya; Rita Ehrlich; Carissa Klaas; Boaris Kaplan; Yara Catoira; Lynne McCranor; Carlos Rospigliosi; Mira Harris
Journal:  Int Ophthalmol       Date:  2008-04-22       Impact factor: 2.031

3.  Identification of Estrogen Signaling in a Prioritization Study of Intraocular Pressure-Associated Genes.

Authors:  Hannah A Youngblood; Emily Parker; Jingwen Cai; Kristin Perkumas; Hongfang Yu; Jason Sun; Sylvia B Smith; Kathryn E Bollinger; Janey L Wiggs; Louis R Pasquale; Michael A Hauser; W Daniel Stamer; Yutao Liu
Journal:  Int J Mol Sci       Date:  2021-09-24       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.